Literature DB >> 12527282

Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells.

Lars Thiele1, Julia E Diederichs, Regina Reszka, Hans P Merkle, Elke Walter.   

Abstract

Serum protein adsorption to the surface of particulate synthetic drug carrier systems has a major influence on their uptake by phagocytes. The influence of alpha2-human serum glycoprotein (alpha2GP) on the phagocytosis of various surface modified microparticles was studied in dendritic cells (DC) and was compared with a potent opsonin, IgG, and a dysopsonin, human serum albumin (HSA). The microparticles were administered to DC before and after the incubation with alpha2GP, IgG and HSA in single, binary or ternary protein systems and in whole blood serum. Phagocytosis of microparticles was vastly affected by the surface character of the microparticles themselves and by the adsorption of the proteins. Poly-L-lysine (PLL)-modified microparticles were under all conditions internalized with highest efficiency which is suggested to be mediated by their positive surface charge. The adsorption of commonly phagocytosis promoting proteins reduced the uptake of PLL-modified particles and is explained by compensation of the positive surface charge by the adsorbed negatively charged proteins. In all other particle types tested, freshly adsorbed alpha2GP was found to exhibit a strong phagocytosis promoting activity which was comparable to that of adsorbed IgG. Interestingly, this opsonic activity was lost already 2 h after adsorption to the particle surface. Protein adsorption from binary and ternary protein systems and from whole blood serum occurred in a competitive manner. Significant inhibition of phagocytosis was observed, even when HSA was combined with strong opsonins such as alpha2GP or IgG or in mixtures of all three proteins, indicating the importance of studying the influence of protein adsorption in protein mixtures. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527282     DOI: 10.1016/s0142-9612(02)00525-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

Review 1.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

2.  Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.

Authors:  Jorge F Coelho; Paula C Ferreira; Patricia Alves; Rosemeyre Cordeiro; Ana C Fonseca; Joana R Góis; Maria H Gil
Journal:  EPMA J       Date:  2010-04-10       Impact factor: 6.543

3.  Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Authors:  Kirk K Hou; Hua Pan; Lee Ratner; Paul H Schlesinger; Samuel A Wickline
Journal:  ACS Nano       Date:  2013-09-26       Impact factor: 15.881

4.  Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier.

Authors:  Kiran Ramanlal Chaudhari; Mukesh Ukawala; Arehalli S Manjappa; Abhinesh Kumar; Piyush Kishor Mundada; Anil Kumar Mishra; Rashi Mathur; Jukka Mönkkönen; Rayasa S Ramchandra Murthy
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

5.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.

Authors:  Susanne Schöttler; Greta Becker; Svenja Winzen; Tobias Steinbach; Kristin Mohr; Katharina Landfester; Volker Mailänder; Frederik R Wurm
Journal:  Nat Nanotechnol       Date:  2016-02-15       Impact factor: 39.213

6.  Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1.

Authors:  Alex J Freemerman; Liyang Zhao; Ajeeth K Pingili; Bin Teng; Alyssa J Cozzo; Ashley M Fuller; Amy R Johnson; J Justin Milner; Maili F Lim; Joseph A Galanko; Melinda A Beck; James E Bear; Jeremy D Rotty; Lavanya Bezavada; Heather S Smallwood; Michelle A Puchowicz; Juan Liu; Jason W Locasale; Douglas P Lee; Brian J Bennett; E Dale Abel; Jeff C Rathmell; Liza Makowski
Journal:  J Immunol       Date:  2019-01-18       Impact factor: 5.422

7.  In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.

Authors:  Yan Sheng; Yuan Yuan; Changsheng Liu; Xinyi Tao; Xiaoqian Shan; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2009-04-14       Impact factor: 3.896

8.  Implant debris particle size affects serum protein adsorption which may contribute to particle size-based bioreactivity differences.

Authors:  Anand Reddy; Marco S Caicedo; Lauryn Samelko; Joshua J Jacobs; Nadim James Hallab
Journal:  J Long Term Eff Med Implants       Date:  2014

9.  Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors.

Authors:  Hyesun Hyun; Joonyoung Park; Kiela Willis; Ji Eun Park; L Tiffany Lyle; Wooin Lee; Yoon Yeo
Journal:  Biomaterials       Date:  2018-07-18       Impact factor: 12.479

10.  Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria.

Authors:  John D Young; Jan Martel; David Young; Andrew Young; Chin-Ming Hung; Lena Young; Ying-Jie Chao; James Young; Cheng-Yeu Wu
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.